2022 ICD-10-CM Code C83.7
Burkitt lymphoma
Not Valid for Submission
| ICD-10: | C83.7 |
| Short Description: | Burkitt lymphoma |
| Long Description: | Burkitt lymphoma |
Code Classification
C83.7 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of burkitt lymphoma. The code is not specific and is NOT valid for the year 2022 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.
Specific Coding for Burkitt lymphoma
Non-specific codes like C83.7 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for burkitt lymphoma:
- BILLABLE CODE - Use C83.70 for Burkitt lymphoma, unspecified site
- BILLABLE CODE - Use C83.71 for Burkitt lymphoma, lymph nodes of head, face, and neck
- BILLABLE CODE - Use C83.72 for Burkitt lymphoma, intrathoracic lymph nodes
- BILLABLE CODE - Use C83.73 for Burkitt lymphoma, intra-abdominal lymph nodes
- BILLABLE CODE - Use C83.74 for Burkitt lymphoma, lymph nodes of axilla and upper limb
- BILLABLE CODE - Use C83.75 for Burkitt lymphoma, lymph nodes of inguinal region and lower limb
- BILLABLE CODE - Use C83.76 for Burkitt lymphoma, intrapelvic lymph nodes
- BILLABLE CODE - Use C83.77 for Burkitt lymphoma, spleen
- BILLABLE CODE - Use C83.78 for Burkitt lymphoma, lymph nodes of multiple sites
- BILLABLE CODE - Use C83.79 for Burkitt lymphoma, extranodal and solid organ sites
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code C83.7:
Inclusion Terms
Inclusion TermsThese terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Atypical Burkitt lymphoma
- Burkitt-like lymphoma
Type 1 Excludes
Type 1 ExcludesA type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
- mature B-cell leukemia Burkitt type C91.A
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code C83.7 are found in the index:
- - Burkitt
- - lymphoma (malignant) - C83.7
- - small noncleaved, diffuse - C83.7
- - undifferentiated - C83.7
- - tumor - C83.7
- - type
- - undifferentiated - C83.7
- - lymphoma (malignant) - C83.7
- - Lymphoma (of) (malignant) - C85.90
- - Burkitt (atypical) - C83.7
- - Burkitt-like - C83.7
Clinical Information
- BURKITT LYMPHOMA-. a form of undifferentiated malignant lymphoma usually found in central africa but also reported in other parts of the world. it is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. b cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of burkitt lymphoma. the epstein barr virus herpesvirus 4 human has been isolated from burkitt lymphoma cases in africa and it is implicated as the causative agent in these cases; however most non african cases are ebv negative.
- HERPESVIRUS 4 HUMAN-. the type species of lymphocryptovirus subfamily gammaherpesvirinae infecting b cells in humans. it is thought to be the causative agent of infectious mononucleosis and is strongly associated with oral hairy leukoplakia leukoplakia hairy; burkitt lymphoma; and other malignancies.
- RECEPTORS CXCR5-. cxcr receptors isolated initially from burkitt lymphoma cells. cxcr5 receptors are expressed on mature recirculating b lymphocytes and are specific for chemokine cxcl13.
Information for Patients
Lymphoma
Lymphoma is a cancer of a part of the immune system called the lymph system. There are many types of lymphoma. One type is Hodgkin disease. The rest are called non-Hodgkin lymphomas.
Non-Hodgkin lymphomas begin when a type of white blood cell, called a T cell or B cell, becomes abnormal. The cell divides again and again, making more and more abnormal cells. These abnormal cells can spread to almost any other part of the body. Most of the time, doctors don't know why a person gets non-Hodgkin lymphoma. You are at increased risk if you have a weakened immune system or have certain types of infections.
Non-Hodgkin lymphoma can cause many symptoms, such as
- Swollen, painless lymph nodes in the neck, armpits or groin
- Unexplained weight loss
- Fever
- Soaking night sweats
- Coughing, trouble breathing or chest pain
- Weakness and tiredness that don't go away
- Pain, swelling or a feeling of fullness in the abdomen
Your doctor will diagnose lymphoma with a physical exam, blood tests, a chest x-ray, and a biopsy. Treatments include chemotherapy, radiation therapy, targeted therapy, biological therapy, or therapy to remove proteins from the blood. Targeted therapy uses drugs or other substances that attack specific cancer cells with less harm to normal cells. Biologic therapy boosts your body's own ability to fight cancer. If you don't have symptoms, you may not need treatment right away. This is called watchful waiting.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)